Wegovy maker Novo Nordisk warns continued copycat-drug competition as it loses U.S. market share
- Posted on August 6, 2025
- By The Globe and Mail
- 2 Views
Wegovy maker Novo Nordisk warns continued copycat-drug competition as it loses U.S. market share
Competition from compounders had Novo cut its full-year sales and profit outlook, $95-billion wiped off company market value
